(JFR) Nuveen Floating Rate Income - Ratings and Ratios

Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US67072T1088 • Bank Loan

JFR: Closed-End, Bank, Loans, Floating, Rate, Debt, Securities

Ticker Symbol: JFR Exchange: NYSE Type: fund Country Origin: USA Fund Style: Bank Loan JFR is a closed-end management investment company primarily focused on floating-rate bank loans, offering exposure to senior secured loans with variable interest rates. The fund seeks to provide a high level of current income while maintaining liquidity. Its portfolio is diversified across various industries, with a focus on credit quality and risk management. JFR is managed by Nuveen, a well-established investment manager with expertise in fixed income strategies.

Average Volume 20d: 792,450 Last Price: 8.45 SMA 20: 8.42 SMA 50: 8.41 SMA 200: 8.37 ATR: 0.07 The fund exhibits low volatility, as indicated by the ATR of 0.07, reflecting minimal price fluctuations. The short-term SMA (20-period) is marginally above the 50-period SMA, suggesting a stable price trend. The 200-period SMA indicates a slightly downward slope, though the overall price action remains tightly range-bound. The average daily volume of 792,450 shares highlights moderate liquidity, allowing for efficient trading without significant market impact.

AUM: 564.06M USD With assets under management (AUM) of $564.06 million, JFR is a mid-sized fund, providing a balance between scale and agility in its investment strategy. Its size allows for diversification across a broad range of bank loans while maintaining access to smaller, niche opportunities. The funds AUM reflects a substantial investor base, contributing to its market presence and stability in the closed-end fund space.

3-Month Forecast: Based on the convergence of the 20-, 50-, and 200-period SMAs near 8.40, JFR is expected to remain range-bound between 8.30 and 8.50 over the next three months. The low ATR of 0.07 suggests minimal volatility, with daily price movements likely to stay within a narrow range. Fundamentally, the stability in AUM and the funds focus on floating-rate loans position it to benefit from rising interest rates, potentially leading to incremental increases in net asset value (NAV) over the forecast period.

Additional Sources for JFR Fund

JFR Fund Overview

Market Cap in USD 564m
Style Bank Loan
IPO / Inception 2004-03-25

JFR Fund Ratings

Growth 5y 74.5%
Fundamental -
Dividend 97.9%
Rel. Strength 5.45
Analysts -
Fair Price Momentum 9.51 USD
Fair Price DCF -

JFR Dividends

Dividend Yield 12m 11.12%
Yield on Cost 5y 20.55%
Annual Growth 5y 10.08%
Payout Consistency 93.7%

JFR Growth Ratios

Growth Correlation 3m -8.3%
Growth Correlation 12m 83.3%
Growth Correlation 5y 77.1%
CAGR 5y 13.24%
CAGR/Max DD 5y 0.65
Sharpe Ratio 12m -0.41
Alpha 4.40
Beta 0.174
Volatility 8.29%
Current Volume 494.5k
Average Volume 20d 720.7k
What is the price of JFR stocks?
As of April 03, 2025, the stock is trading at USD 8.47 with a total of 494,547 shares traded.
Over the past week, the price has changed by +0.36%, over one month by +0.54%, over three months by -2.83% and over the past year by +9.12%.
Is Nuveen Floating Rate Income a good stock to buy?
Yes. Based on ValueRay Analyses, Nuveen Floating Rate Income (NYSE:JFR) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.54 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JFR as of April 2025 is 9.51. This means that JFR is currently undervalued and has a potential upside of +12.28% (Margin of Safety).
Is JFR a buy, sell or hold?
Nuveen Floating Rate Income has no consensus analysts rating.
What are the forecast for JFR stock price target?
According to ValueRays Forecast Model, JFR Nuveen Floating Rate Income will be worth about 10.3 in April 2026. The stock is currently trading at 8.47. This means that the stock has a potential upside of +21.84%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.3 21.8%